Animal Vaccine Market Size and Outlook 2030

Report Description

Forecast Period	2026-2030
Market Size (2024)	USD 7.68 Billion
CAGR (2025-2030)	8.69%
Fastest Growing Segment	Livestock
Largest Market	North America
Market Size (2030)	USD 12.66 Billion

Market Overview

The Global Animal Vaccine Market , valued at USD 7.68 Billion in 2024, is projected to experience a CAGR of 8.69% to reach USD 12.66 Billion by 2030. The global animal vaccine market comprises biological preparations designed to stimulate immunity against infectious diseases across various animal species, including livestock and companion animals. These vaccines are crucial for disease prevention, mortality reduction, and public health protection by controlling zoonotic transmission. Primary market drivers include the rising incidence of zoonotic diseases, the increasing global demand for animal-derived protein, and heightened awareness of animal welfare.

A significant market expansion challenge is the substantial cost associated with vaccine research, development, and stringent regulatory approval processes. This elevates production expenses, affecting vaccine accessibility and affordability, especially in developing economies. Highlighting the persistent threat, according to the World Organisation for Animal Health (WOAH), between January 2024 and May 2025, there were 6,346 outbreaks of high pathogenicity avian influenza, resulting in 148.68 million animal losses in poultry.

Key Market Drivers

The global animal vaccine market is primarily influenced by the rising incidence of zoonotic diseases and the increasing global demand for animal-derived food products. Zoonotic diseases, transmissible between animals and humans, necessitate extensive animal vaccination to mitigate public health risks. For example, according to Forbes, in December 2024, a major mpox epidemic in the Democratic Republic of the Congo and neighboring countries recorded over 16,000 confirmed cases, prompting a public health emergency declaration from the World Health Organization. This underscores the critical role of veterinary vaccines in preventing disease transmission at the human-animal interface. Simultaneously, the escalating global demand for animal protein fuels livestock expansion, increasing disease susceptibility in concentrated animal populations. According to the Food and Agriculture Organization of the United Nations, in December 2024, global meat production was anticipated to reach 373 million tons, marking a 1.4% increase from 2023. Proactive vaccination ensures animal health, safeguarding food security and preventing significant economic losses in this expanding sector.

Beyond these fundamental drivers, the market benefits from continuous innovation and robust regulatory support. In 2024, for instance, the European Medicines Agency recommended 14 veterinary vaccines for marketing authorization, a 55% increase over 2023, signaling a dynamic industry commitment to animal health solutions.

Download Free Sample Report

Key Market Challenges

The substantial cost associated with vaccine research, development, and stringent regulatory approval processes represents a significant impediment to the expansion of the Global Animal Vaccine Market. These extensive financial requirements elevate production expenses, directly impacting vaccine accessibility and affordability, particularly within developing economies where resources are often constrained. The prolonged timelines and complex regulatory pathways demand considerable capital investment, which restricts the number of new vaccines brought to market and limits the capacity for existing ones to be widely distributed at competitive prices.

This financial hurdle demonstrably slows market penetration. For example, according to the World Organisation for Animal Health (WOAH), in April 2023, approximately 27.5 million doses of rabies vaccine were delivered to countries in Asia and Africa, alongside 8.1 million foot and mouth disease vaccines and 91.6 million doses of peste des petits ruminants vaccine. Despite these substantial efforts, the underlying high costs of development and regulatory navigation mean that reaching the entire animal population in need remains a persistent challenge, ultimately decelerating overall market growth and hindering comprehensive disease prevention efforts globally.

Key Market Trends

The Global Animal Vaccine Market is significantly influenced by the rapid advancements in next-generation vaccine technologies. This trend encompasses the development of more sophisticated solutions such as recombinant, subunit, and mRNA-based vaccines, moving beyond traditional attenuated or inactivated forms. These innovative vaccines offer enhanced efficacy, improved safety profiles, and often enable faster development cycles and more targeted protection against specific pathogens. According to the World Health Organization's (WHO) 2024 Global Vaccine Market Report, in 2023, 88 vaccine products were sold across 207 countries by 116 manufacturers, underscoring the broad market where technological advancements are being applied. In January 2025, Ceva Sante Animale acquired Scout Bio to expand its portfolio into veterinary biologics and gene therapies, further illustrating industry investment in advanced immunological solutions.

Another pivotal trend is the escalating digital transformation in animal health management. This involves the integration of technologies like the Internet of Things (IoT), artificial intelligence (AI), and data analytics to provide real-time monitoring, enhance disease surveillance, facilitate precision vaccination programs, and optimize overall herd health management. This shift allows for a more proactive approach to animal health, improving operational efficiency and resource allocation. According to the American Pet Products Association (APPA), in 2023, U. S. households allocated USD 38.3 billion towards veterinary care and product sales, indicating a substantial market where digital efficiencies are highly valued. MSD Animal Health, in November 2024, recognized innovations in swine technology for their Pignnovation Award, including solutions utilizing data and artificial intelligence for sow body condition score monitoring and enhanced traceability, demonstrating practical applications of this trend.

Segmental Insights

The Livestock segment stands out as the most rapidly growing within the Global Animal Vaccine Market, driven by a confluence of significant factors. Primarily, the escalating global demand for animal-derived food products, such as meat and dairy, to meet the needs of an expanding population and changing dietary preferences necessitates robust animal health management, including widespread vaccination programs. This demand is compounded by the increasing frequency of livestock disease outbreaks globally, which underscores the critical role of vaccines in preventing significant economic losses for producers and safeguarding food security. Additionally, growing awareness among farmers regarding the importance of preventive animal healthcare, coupled with favorable government initiatives supporting animal health and disease control, further stimulates market expansion.

Regional Insights

North America leads the Global Animal Vaccine Market due to a confluence of well-established factors. The region experiences a significant prevalence of both livestock and zoonotic diseases, which consistently drives demand for effective vaccination programs. A robust veterinary healthcare infrastructure, coupled with advanced research facilities and a strong presence of major pharmaceutical and biotechnology companies, fosters continuous innovation and product commercialization. Furthermore, stringent regulatory oversight by bodies such as the United States Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) Center for Veterinary Biologics ensures product quality and efficacy. Increasing pet ownership and heightened awareness of animal health and food safety also contribute significantly to vaccine adoption across the region.

Recent Developments

In June 2025, Elanco Animal Health announced a strategic partnership with Medgene to leverage innovative vaccine technology. This collaboration is focused on the commercialization of a Highly Pathogenic Avian Influenza (HPAI) vaccine for dairy cattle, once it receives regulatory approval. This initiative demonstrates a proactive approach within the global animal vaccine market to address significant livestock diseases and enhance animal care. The partnership signifies a commitment to advancing solutions for emerging health threats through joint research and development efforts.

In September 2024, Merck Animal Health expanded its innovative NOBIVAC NXT vaccine platform with the introduction of a new feline leukemia virus (FeLV) vaccine. This product launch in the global animal vaccine market leveraged RNA-particle technology, a breakthrough scientific achievement, to provide optimized protection for cats against one of the most common infectious feline diseases. The vaccine is a non-adjuvanted, low-volume 0.5 mL dose, designed to promote robust immune responses while maintaining patient comfort and safety. It was anticipated to become available in veterinary clinics nationwide that fall.

In June 2024, Merck Animal Health announced the U.S. Department of Agriculture's approval of NOBIVAC NXT Canine Flu H3N2, marking a significant new product launch in the global animal vaccine market. This vaccine is the first for canine influenza to utilize RNA-particle technology, designed to elicit a precise immune response against the prevalent H3N2 strain. The non-adjuvanted, low-volume 0.5 mL dose represents a breakthrough in vaccine technology, aiming to provide optimized protection for dogs and address evolving needs in veterinary care. It became available to veterinary clinics across the United States later that summer.

In 2024, Boehringer Ingelheim, in collaboration with Bioveta, rapidly co-developed and launched a vaccine for bluetongue virus (BTV) serotype 3. This collaboration addressed an urgent need within the livestock sector to protect against the infectious transboundary disease affecting multiple species. The swift development and market introduction underscore Boehringer Ingelheim's commitment to innovation through partnerships in the animal health industry. This product launch was a key highlight for the company's animal health division, demonstrating their ability to respond effectively to emerging disease challenges.

Key Market Players

Zoetis Inc.
Merck & Co., Inc.
Boehringer Ingelheim International GmbH
Biogenesis Bago SA
Indian Immunologicals Ltd.
Elanco Animal Health Incorporated
Phibro Animal Health Corporation
Neogen Corporation
Intas Pharmaceuticals Ltd.
Ouro Fino Saude Animal

By Product	By Animal Type	By Route Of Administration	By Distribution Channel	By Region
Attenuated Live Vaccines Inactivated Vaccines Subunit Vaccines DNA Vaccines Recombinant Vaccines	Livestock Companion Others	Subcutaneous Intramuscular Intranasal	Veterinary Hospitals Veterinary Clinics Pharmacies & Drug Stores Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Animal Vaccine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Animal Vaccine Market , By Product:

o Attenuated Live Vaccines

o Inactivated Vaccines

o Subunit Vaccines

o DNA Vaccines

o Recombinant Vaccines

Animal Vaccine Market , By Animal Type:

o Livestock

o Companion

o Others

Animal Vaccine Market , By Route Of Administration:

o Subcutaneous

o Intramuscular

o Intranasal

Animal Vaccine Market , By Distribution Channel:

o Veterinary Hospitals

o Veterinary Clinics

o Pharmacies & Drug Stores

o Others

Animal Vaccine Market , By Region:

o North America

§ United States

§ Canada

§ Mexico

o Europe

§ France

§ United Kingdom

§ Italy

§ Germany

§ Spain

o Asia Pacific

§ China

§ India

§ Japan

§ Australia

§ South Korea

o South America

§ Brazil

§ Argentina

§ Colombia

o Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Animal Vaccine Market .

Available Customizations:

Global Animal Vaccine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Animal Vaccine Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Animal Vaccine Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)

5.2.2. By Animal Type (Livestock, Companion, Others)

5.2.3. By Route Of Administration (Subcutaneous, Intramuscular, Intranasal)

5.2.4. By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others)

5.2.5. By Region

5.2.6. By Company (2024)

5.3. Market Map

6. North America Animal Vaccine Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Product

6.2.2. By Animal Type

6.2.3. By Route Of Administration

6.2.4. By Distribution Channel

6.2.5. By Country

6.3. North America: Country Analysis

6.3.1. United States Animal Vaccine Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Product

6.3.1.2.2. By Animal Type

6.3.1.2.3. By Route Of Administration

6.3.1.2.4. By Distribution Channel

6.3.2. Canada Animal Vaccine Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Product

6.3.2.2.2. By Animal Type

6.3.2.2.3. By Route Of Administration

6.3.2.2.4. By Distribution Channel

6.3.3. Mexico Animal Vaccine Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Product

6.3.3.2.2. By Animal Type

6.3.3.2.3. By Route Of Administration

6.3.3.2.4. By Distribution Channel

7. Europe Animal Vaccine Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Product

7.2.2. By Animal Type

7.2.3. By Route Of Administration

7.2.4. By Distribution Channel

7.2.5. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Animal Vaccine Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Product

7.3.1.2.2. By Animal Type

7.3.1.2.3. By Route Of Administration

7.3.1.2.4. By Distribution Channel

7.3.2. France Animal Vaccine Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Product

7.3.2.2.2. By Animal Type

7.3.2.2.3. By Route Of Administration

7.3.2.2.4. By Distribution Channel

7.3.3. United Kingdom Animal Vaccine Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Product

7.3.3.2.2. By Animal Type

7.3.3.2.3. By Route Of Administration

7.3.3.2.4. By Distribution Channel

7.3.4. Italy Animal Vaccine Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Product

7.3.4.2.2. By Animal Type

7.3.4.2.3. By Route Of Administration

7.3.4.2.4. By Distribution Channel

7.3.5. Spain Animal Vaccine Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Product

7.3.5.2.2. By Animal Type

7.3.5.2.3. By Route Of Administration

7.3.5.2.4. By Distribution Channel

8. Asia Pacific Animal Vaccine Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Product

8.2.2. By Animal Type

8.2.3. By Route Of Administration

8.2.4. By Distribution Channel

8.2.5. By Country

8.3. Asia Pacific: Country Analysis

8.3.1. China Animal Vaccine Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Product

8.3.1.2.2. By Animal Type

8.3.1.2.3. By Route Of Administration

8.3.1.2.4. By Distribution Channel

8.3.2. India Animal Vaccine Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Product

8.3.2.2.2. By Animal Type

8.3.2.2.3. By Route Of Administration

8.3.2.2.4. By Distribution Channel

8.3.3. Japan Animal Vaccine Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Product

8.3.3.2.2. By Animal Type

8.3.3.2.3. By Route Of Administration

8.3.3.2.4. By Distribution Channel

8.3.4. South Korea Animal Vaccine Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Product

8.3.4.2.2. By Animal Type

8.3.4.2.3. By Route Of Administration

8.3.4.2.4. By Distribution Channel

8.3.5. Australia Animal Vaccine Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Product

8.3.5.2.2. By Animal Type

8.3.5.2.3. By Route Of Administration

8.3.5.2.4. By Distribution Channel

9. Middle East & Africa Animal Vaccine Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Product

9.2.2. By Animal Type

9.2.3. By Route Of Administration

9.2.4. By Distribution Channel

9.2.5. By Country

9.3. Middle East & Africa: Country Analysis

9.3.1. Saudi Arabia Animal Vaccine Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Product

9.3.1.2.2. By Animal Type

9.3.1.2.3. By Route Of Administration

9.3.1.2.4. By Distribution Channel

9.3.2. UAE Animal Vaccine Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Product

9.3.2.2.2. By Animal Type

9.3.2.2.3. By Route Of Administration

9.3.2.2.4. By Distribution Channel

9.3.3. South Africa Animal Vaccine Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Product

9.3.3.2.2. By Animal Type

9.3.3.2.3. By Route Of Administration

9.3.3.2.4. By Distribution Channel

10. South America Animal Vaccine Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Product

10.2.2. By Animal Type

10.2.3. By Route Of Administration

10.2.4. By Distribution Channel

10.2.5. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Animal Vaccine Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Product

10.3.1.2.2. By Animal Type

10.3.1.2.3. By Route Of Administration

10.3.1.2.4. By Distribution Channel

10.3.2. Colombia Animal Vaccine Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Product

10.3.2.2.2. By Animal Type

10.3.2.2.3. By Route Of Administration

10.3.2.2.4. By Distribution Channel

10.3.3. Argentina Animal Vaccine Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Product

10.3.3.2.2. By Animal Type

10.3.3.2.3. By Route Of Administration

10.3.3.2.4. By Distribution Channel

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)

12.2. Product Launches (If Any)

12.3. Recent Developments

13. Global Animal Vaccine Market : SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Zoetis Inc.

15.1.1. Business Overview

15.1.2. Products & Services

15.1.3. Recent Developments

15.1.4. Key Personnel

15.1.5. SWOT Analysis

15.2. Merck & Co., Inc.

15.3. Boehringer Ingelheim International GmbH

15.4. Biogenesis Bago SA

15.5. Indian Immunologicals Ltd.

15.6. Elanco Animal Health Incorporated

15.7. Phibro Animal Health Corporation

15.8. Neogen Corporation

15.9. Intas Pharmaceuticals Ltd.

15.10. Ouro Fino Saude Animal

16. Strategic Recommendations

17. About Us & Disclaimer

Report Description

Table of content

Figures and Tables

Frequently asked questions

What was the market size of the Global Animal Vaccine Market in 2024?

Which is the dominating region in the Global Animal Vaccine Market ?

Which is the fastest growing segment in the Global Animal Vaccine Market ?

What is the expected growth rate of the Global Animal Vaccine Market ?